Antimalarial immunomodulator

This page covers all Antimalarial immunomodulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Lysosomal function; TLR signaling, Toll-like receptors (TLR), lysosomal pH modulation, Toll-like receptors (TLR); lysosomal pH modulation.

Targets

Lysosomal function; TLR signaling · Toll-like receptors (TLR), lysosomal pH modulation · Toll-like receptors (TLR); lysosomal pH modulation · TLR7, TLR9, and lysosomal pH-dependent pathways

Marketed (3)

• Hydroxychloroquine reduced · University of Sao Paulo General Hospital · Immunology; Rheumatology
  Hydroxychloroquine is a quinoline antimalarial and immunomodulatory agent that inhibits lysosomal function and reduces inflammatory cytokine production.
• Hydroxychloroquine Sulfate Loading Dose · Government of Punjab, Specialized Healthcare and Medical Education Department · Immunology, Rheumatology, Infectious Disease
  Hydroxychloroquine is an antimalarial and immunomodulatory agent that inhibits toll-like receptor signaling and reduces inflammatory cytokine production.
• Single Dose of Hydroxychloroquine · Shahid Beheshti University of Medical Sciences · Immunology; Rheumatology
  Hydroxychloroquine is an antimalarial and immunomodulatory agent that inhibits toll-like receptor signaling and reduces inflammatory cytokine production.

Phase 3 pipeline (2)

• Hydroxychloroquine Oral Product · Hospital do Coracao · Immunology, Rheumatology
  Hydroxychloroquine is an antimalarial and immunomodulatory agent that inhibits toll-like receptor signaling and reduces inflammatory cytokine production.
• Hydroxychloroquine (HCQ) · Post Graduate Institute of Medical Education and Research, Chandigarh · Immunology, Rheumatology
  Hydroxychloroquine is a quinoline antimalarial and immunomodulatory agent that inhibits toll-like receptor signaling and reduces inflammatory cytokine production.